T
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Price:
8.67
CNY
1.17%
Market Closed
Market Cap:
¥17B
Relative Value
The Relative Value of one Tonghua Dongbao Pharmaceutical Co Ltd stock under the Base Case scenario is 7.48 CNY. Compared to the current market price of 8.67 CNY, Tonghua Dongbao Pharmaceutical Co Ltd is Overvalued by 14%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
7.48
CNY
Overvaluation 14%
T
Multiples Across Competitors
Competitors Multiples
Tonghua Dongbao Pharmaceutical Co Ltd Competitors
Tonghua Dongbao Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
T
|
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
|
17B CNY | 6.2 | 13.9 | 48.1 | 48.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
948.8B USD | 16 | 51.5 | 34.6 | 37.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
563B USD | 6 | 21 | 14.6 | 17.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
286.3B CHF | 4.7 | 30.4 | 12.8 | 15 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.6B GBP | 5.1 | 31.6 | 15.1 | 22.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288.1B USD | 4.5 | 15.1 | 10.7 | 12.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
224.1B CHF | 5.2 | 20.1 | 12.6 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.3 | 9.3 | 10.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD | 2.3 | 14.9 | 7.6 | 10.3 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98.2B EUR | 1.7 | 8.2 | 7.7 | 7.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
